Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

CSAN March 10, 2026

Cosan Q4 2025 Earnings Call - Major deleveraging progress, but Raízen capital fix remains unresolved

Cosan closed Q4 2025 with mixed operational resilience and a heavy focus on cleaning up its balance sheet. Managed EBITDA was BRL 7.8 billion in the quarter, roughly flat year on year, while full-year...

  • Managed EBITDA: Q4 2025 managed EBITDA was BRL 7.8 billion, broadly flat versus Q4 2024; full-year managed EBITDA fell to BRL 26.5 billion, mainly due to Raízen and Radar.
  • Net result: Cosan SA reported an adjusted net loss of BRL 0.7 billion in Q4 and an adjusted net loss of BRL 4.0 billion for full-year 2025, driven by lower equity income from subsidiaries.
  • Dividends and cash in: Dividends and interest on equity received were BRL 479 million in the quarter, BRL 2.6 billion for the year versus BRL 4.3 billion in 2024, reflecting lower distributions from Moove and Compass.
  • +13 more takeaways
CTOS March 10, 2026

Custom Truck One Source Q4 2025 Earnings Call - Rental rebound drives record revenue with utilization near 84%

Custom Truck closed 2025 on a high note, led by a rental business revival that pushed quarterly revenue to $528 million and drove adjusted EBITDA to $121 million, up more than 18% year over year. For ...

  • Q4 revenue $528 million, adjusted EBITDA $121 million, both reflecting stronger operating performance and rental strength.
  • Full year 2025 record revenue $1.944 billion, adjusted EBITDA $384 million, up 8% and 13% versus 2024 respectively, ahead of guidance midpoint.
  • Rental utilization hit multiyear highs, averaging just under 84% in Q4 (CFO cited 83.6%), and was approximately 82% early in 2026.
  • +12 more takeaways
CASY March 10, 2026

Casey’s General Stores Q3 FY2026 Earnings Call - Margin Expansion and M&A Synergies Drive 50% EPS Jump

Casey’s posted a heavy headline quarter. EPS came in at $3.49, up 50% year over year, with net income of $130 million and EBITDA of $309 million, driven by inside margin expansion and stronger fuel gr...

  • Diluted EPS $3.49, up 50% YoY; net income $130 million, up 49%; EBITDA $309 million, up 27.5% — clear beat driven by margin leverage.
  • Total revenue $3.91 billion, essentially flat YoY; inside sales grew to $1.48 billion, up 5.7% driven by prepared food and grocery.
  • Inside gross profit margin 42.2%, up 130 basis points YoY; prepared food margin 58.3% (up 50 bps); grocery and general merchandise margin 35.7%, up 150 bps.
  • +12 more takeaways
UNFI March 10, 2026

UNFI Second Quarter Fiscal 2026 Earnings Call - Profitability and Free Cash Flow Accelerate as Network Optimization Compresses Sales but Deleveraging Advances

UNFI reported a mixed quarter: sales weakened due to planned, accretive network optimization, but operational changes drove outsized improvements in profitability and cash generation. Management pushe...

  • Q2 net sales about $8 billion, down 2.6% year over year, with roughly a 500 basis point negative impact from accretive network optimization activity.
  • Natural product sales grew 7% in Q2, outperforming the market and driven by sustained shopper demand and some short-term project work that may wind down in H2 2026.
  • Conventional product sales declined 12%, primarily reflecting the accelerated exit and consolidation of the Allentown distribution center and other optimization moves.
  • +13 more takeaways
XGN March 10, 2026

Exagen Incorporated Q4 2025 Earnings Call - Volume Momentum Hits Records, ASP Reset Delays Break-even

Exagen closed 2025 with clear commercial momentum and a tidy narrative: record revenue and accelerating test volume, but pricing pressures and new product costs have pushed the firm’s profitability in...

  • Full-year 2025 revenue was $66.6 million, up nearly 20% versus 2024.
  • Total AVISE CTD test volume for 2025 reached 137,000, driven by a second-half inflection and Q4 being the company’s highest Q4 on record.
  • Trailing 12-month ASP ended 2025 at approximately $441, up about 7% from the start of the year, but in-period ASP exited Q4 nearer to $430, reflecting a recent reset.
  • +16 more takeaways
GLRE March 10, 2026

Greenlight Capital Re, Ltd. Fourth Quarter 2025 Earnings Call - Underwriting Strength and Solasglas Gains Lifted Record 2025

Greenlight Re closed 2025 with a clean, unmistakable beat driven by underwriting and its Solasglas investment. Q4 produced a $13 million underwriting profit and a $36.2 million mark from Solasglas, co...

  • Q4 2025 underwriting profit of $13.0 million, combined ratio 92.1% (10th underwriting profit in 12 quarters).
  • Solasglas investment returned $36.2 million in Q4, a 7.9% quarterly gain, driving $44.8 million of net investment income for the quarter.
  • Net income for Q4 was $49.3 million, and full year 2025 net income was $74.8 million, lifting fully diluted book value per share to $20.43, up 13.8% year-over-year.
  • +14 more takeaways
NPWR March 10, 2026

NET Power Inc. Q4 2025 Earnings Call - Pivot to GT plus PCC with Entropy to Race for Permian FID

NET Power announced a decisive strategic pivot away from oxy-combustion toward a combined cycle gas turbine plus post-combustion capture solution, working with Entropy and OEM partners to deliver a pr...

  • NET Power formally pivoted away from oxy-combustion as its near-term commercial path, preserving the work but prioritizing a GT plus PCC route.
  • New integrated product pairs 2 Siemens SGT-A35 turbines, prepackaged by Relevant Power Solutions, with Entropy solvent-based post-combustion capture, targeting >90% CO2 capture.
  • Project Permian passed conceptual design review, and detailed design with WSP is underway, de-risking engineering and cost assumptions.
  • +12 more takeaways
NUWE March 10, 2026

Nuwellis Fourth Quarter 2025 Earnings Call - Manufacturing reset, Rendiatech buy, and $1.2M cash on hand

Nuwellis used 2025 as a reset year, shifting from broad market push to a concentrated cardiorenal strategy, moving manufacturing to KDI for reliability, and buying Rendiatech to bolster ICU diagnostic...

  • Company repositioned around the cardiorenal continuum, prioritizing heart failure and pediatrics where clinical pull and economic value align.
  • Fourth quarter 2025 revenue was $2.4 million, up 4% year-over-year and 9% sequentially, driven by increased utilization and console sales.
  • Full-year 2025 revenue was $8.3 million, a 5% decline versus 2024, reflecting lower consumable utilization and reduced international contributions.
  • +12 more takeaways
ABM March 10, 2026

ABM Industries Q1 2026 Earnings Call - Strong organic growth and cash, Technical Solutions timing weighed margins

ABM posted a solid Q1 with 5.5% organic revenue growth, $2.2 billion in revenue, and roughly $49 million in free cash flow, while management kept full year guidance intact. The quarter’s weakness was ...

  • Revenue $2.2 billion, up 6.1% year over year, driven by 5.5% organic growth.
  • Q1 net income $38.8 million, $0.64 per diluted share; adjusted net income $50.4 million, $0.83 per diluted share.
  • Free cash flow nearly $49 million in the quarter, a marked improvement driven by working capital management and ERP stabilization.
  • +13 more takeaways
KVHI March 10, 2026

KVH Industries, Inc. Q4 2025 Earnings Call - LEO Pivot Proves Out with Strong Subscriber Growth and Starlink Commitment

KVH says 2025 was the year its deliberate pivot to LEO-led maritime connectivity started to pay off. Q4 service revenue jumped to $28.3 million, service subscribers topped 9,000 vessels after adding r...

  • KVH is executing a strategic pivot from GEO to LEO-focused maritime connectivity, and management says 2025 proved the strategy is working.
  • Q4 service revenue was $28.3 million, up 27% versus Q4 2024. Full-year service revenue was $98.4 million, up 2% year over year.
  • Stripping out a $7.7 million one-time US Coast Guard contract, underlying service revenue grew about 11% in 2025, a better indicator of core momentum.
  • +11 more takeaways